Hyperfine (HYPR) Stock Forecast, Price Target & Predictions
HYPR Stock Forecast
Hyperfine stock forecast is as follows: an average price target of $1.60 (represents a 80.77% upside from HYPR’s last price of $0.89) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
HYPR Price Target
The average price target for Hyperfine (HYPR) is $1.60 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $1.60 to $1.60. This represents a potential 80.77% upside from HYPR's last price of $0.89.
HYPR Analyst Ratings
According to 4 Wall Street analysts, Hyperfine's rating consensus is 'Buy'. The analyst rating breakdown for HYPR stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Hyperfine Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 22, 2024 | Larry Biegelsen | Wells Fargo | $1.60 | $1.01 | 58.42% | 80.77% |
| Aug 11, 2022 | Larry Biegelsen | Wells Fargo | $2.40 | $1.50 | 60.00% | 171.16% |
The latest Hyperfine stock forecast, released on Mar 22, 2024 by Larry Biegelsen from Wells Fargo, set a price target of $1.60, which represents a 58.42% increase from the stock price at the time of the forecast ($1.01), and a 80.77% increase from HYPR last price ($0.89).
Hyperfine Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $1.60 |
| Last Closing Price | $0.89 | $0.89 | $0.89 |
| Upside/Downside | -100.00% | -100.00% | 80.77% |
In the current month, the average price target of Hyperfine stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Hyperfine's last price of $0.89. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 09, 2024 | B. Riley | Buy | Buy | Hold |
| May 14, 2024 | Jefferies | Hold | Downgrade | |
| Oct 04, 2022 | B. Riley | Buy | Initialise | |
| Oct 03, 2022 | Prescience Point | Buy | Initialise | |
| Aug 11, 2022 | Wells Fargo | Overweight | Downgrade |
Hyperfine's last stock rating was published by B. Riley on Aug 09, 2024. The company gave HYPR a "Buy" rating, the same as its previous rate.
Hyperfine Financial Forecast
Hyperfine Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $2.69M | $2.33M | $3.38M | $2.63M | $1.42M | $2.35M | $1.53M | $1.51M |
| Avg Forecast | $6.84M | $6.03M | $5.32M | $4.69M | $3.70M | $3.30M | $3.26M | $3.05M | $3.71M | $2.95M | $3.20M | $2.07M | $2.50M | $1.70M | $2.00M | $1.00M |
| High Forecast | $7.32M | $6.46M | $5.69M | $5.02M | $3.89M | $3.30M | $3.26M | $3.05M | $3.75M | $3.16M | $3.43M | $2.21M | $2.68M | $1.70M | $2.00M | $1.00M |
| Low Forecast | $6.59M | $5.81M | $5.13M | $4.52M | $3.50M | $3.30M | $3.26M | $3.05M | $3.67M | $2.84M | $3.09M | $1.99M | $2.41M | $1.70M | $2.00M | $1.00M |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 0.72% | 0.79% | 1.06% | 1.28% | 0.57% | 1.38% | 0.77% | 1.51% |
Hyperfine's average Quarter revenue forecast for Mar 24 based on 1 analysts is $3.05M, with a low forecast of $3.05M, and a high forecast of $3.05M. HYPR's average Quarter revenue forecast represents a 13.68% increase compared to the company's last Quarter revenue of $2.69M (Dec 23).
Hyperfine EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-11.63M | $-11.76M | $-11.43M | $-12.78M | $-13.37M | $-13.04M | $-22.93M | $-23.52M |
| Avg Forecast | $-4.10M | $-3.62M | $-3.19M | $-2.81M | $-2.22M | $-1.98M | $-1.96M | $-1.83M | $-2.22M | $-1.77M | $-1.92M | $-1.24M | $-1.50M | $-1.02M | $-1.20M | $-9.86M |
| High Forecast | $-3.96M | $-3.49M | $-3.08M | $-2.71M | $-2.10M | $-1.98M | $-1.96M | $-1.83M | $-2.20M | $-1.71M | $-1.85M | $-1.20M | $-1.45M | $-1.02M | $-1.20M | $-7.89M |
| Low Forecast | $-4.39M | $-3.87M | $-3.42M | $-3.01M | $-2.33M | $-1.98M | $-1.96M | $-1.83M | $-2.25M | $-1.90M | $-2.06M | $-1.33M | $-1.61M | $-1.02M | $-1.20M | $-11.83M |
| Surprise % | - | - | - | - | - | - | - | - | 5.23% | 6.64% | 5.95% | 10.31% | 8.91% | 12.79% | 19.11% | 2.39% |
undefined analysts predict HYPR's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Hyperfine's previous annual EBITDA (undefined) of $NaN.
Hyperfine Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-10.68M | $-10.76M | $-10.64M | $-11.29M | $-12.69M | $-12.89M | $-23.09M | $-23.78M |
| Avg Forecast | $-10.87M | $-10.98M | $-9.35M | $-9.35M | $-9.38M | $-10.18M | $-10.18M | $-10.66M | $-13.14M | $-12.11M | $-12.36M | $-9.45M | $-15.95M | $-18.49M | $-21.61M | $-9.96M |
| High Forecast | $-10.37M | $-10.47M | $-8.92M | $-8.92M | $-9.30M | $-9.70M | $-9.70M | $-10.17M | $-12.37M | $-11.55M | $-11.78M | $-9.01M | $-15.21M | $-18.49M | $-21.61M | $-7.97M |
| Low Forecast | $-11.88M | $-12.00M | $-10.22M | $-10.22M | $-9.46M | $-11.12M | $-11.12M | $-11.65M | $-13.92M | $-13.24M | $-13.50M | $-10.32M | $-17.42M | $-18.49M | $-21.61M | $-11.96M |
| Surprise % | - | - | - | - | - | - | - | - | 0.81% | 0.89% | 0.86% | 1.19% | 0.80% | 0.70% | 1.07% | 2.39% |
Hyperfine's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HYPR's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Hyperfine SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $6.70M | $7.14M | $7.80M | $8.73M | $8.71M | $6.63M | $15.76M | $15.52M |
| Avg Forecast | $88.26M | $77.82M | $68.61M | $60.50M | $47.76M | $42.56M | $42.13M | $39.42M | $47.85M | $38.08M | $41.31M | $26.68M | $32.27M | $21.95M | $25.82M | $12.91M |
| High Forecast | $94.55M | $83.36M | $73.50M | $64.81M | $50.21M | $42.56M | $42.13M | $39.42M | $48.37M | $40.80M | $44.25M | $28.58M | $34.57M | $21.95M | $25.82M | $12.91M |
| Low Forecast | $85.12M | $75.05M | $66.17M | $58.34M | $45.20M | $42.56M | $42.12M | $39.41M | $47.33M | $36.73M | $39.84M | $25.73M | $31.12M | $21.95M | $25.82M | $12.91M |
| Surprise % | - | - | - | - | - | - | - | - | 0.14% | 0.19% | 0.19% | 0.33% | 0.27% | 0.30% | 0.61% | 1.20% |
Hyperfine's average Quarter SG&A projection for Mar 24 is $39.42M, based on 1 Wall Street analysts, with a range of $39.41M to $39.42M. The forecast indicates a 488.21% rise compared to HYPR last annual SG&A of $6.70M (Dec 23).
Hyperfine EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.15 | $-0.15 | $-0.15 | $-0.16 | $-0.18 | $-0.18 | $-0.33 | $-0.34 |
| Avg Forecast | $-0.15 | $-0.15 | $-0.13 | $-0.13 | $-0.13 | $-0.14 | $-0.14 | $-0.15 | $-0.18 | $-0.17 | $-0.17 | $-0.13 | $-0.22 | $-0.26 | $-0.30 | $-0.21 |
| High Forecast | $-0.14 | $-0.14 | $-0.12 | $-0.12 | $-0.13 | $-0.13 | $-0.13 | $-0.14 | $-0.17 | $-0.16 | $-0.16 | $-0.12 | $-0.21 | $-0.26 | $-0.30 | $-0.21 |
| Low Forecast | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.15 | $-0.15 | $-0.16 | $-0.19 | $-0.18 | $-0.19 | $-0.14 | $-0.24 | $-0.26 | $-0.30 | $-0.21 |
| Surprise % | - | - | - | - | - | - | - | - | 0.83% | 0.90% | 0.88% | 1.23% | 0.82% | 0.70% | 1.10% | 1.62% |
According to undefined Wall Street analysts, Hyperfine's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HYPR previous annual EPS of $NaN (undefined).
Hyperfine Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| APYX | Apyx Medical | $1.64 | $8.50 | 418.29% | Buy |
| INGN | Inogen | $9.12 | $26.00 | 185.09% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| HYPR | Hyperfine | $0.94 | $1.60 | 70.21% | Buy |
| LIVN | LivaNova | $49.94 | $68.25 | 36.66% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| IRMD | IRadimed | $53.00 | $60.00 | 13.21% | Buy |
| ITGR | Integer | $136.68 | $153.50 | 12.31% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |